Applied Therapeutics, Inc. — Director's Dealing 2022

Mar 18, 2022

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Applied Therapeutics Inc. (APLT)
CIK: 0001697532
Period of Report: 2022-03-08

Reporting Person: Ortega Steven A. (Principal Accounting Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	12323	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee Stock Option (right to buy)	$14.20	2031-09-13	Common Stock (19707)		Direct

Footnotes

F1: Includes 9,242 unvested compensatory Restricted Stock Units.

F2: Consists of compensatory Options. One-fourth (1/4th) of the shares subject to the compensatory Option vested on February 1, 2022, and one thirty-sixth (1/36th) of the remaining shares subject to the compensatory Option shall vest each month thereafter, subject to the Reporting Person continuing to provide services through each such date.